cholic acid has been researched along with Cystic Fibrosis of Pancreas in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barth, A; Barucha, A; Kauf, E; Lehmann, T; Lüth, S; Mainz, JG; Schneider, J; Tabori, H; Zagoya, C | 1 |
| Aksenov, A; Arthur, TD; Avila-Pacheco, J; Bae, S; Belda-Ferre, P; Bodai, Z; Boland, BS; Bussell, R; Chang, JT; Christy, MP; Chung, LK; Clish, C; da Silva, R; Dorrestein, PC; Downes, M; Egan, M; Evans, RM; Ferguson, D; Franzosa, EA; Fu, T; Garg, N; Gauglitz, JM; Gentry, E; Haddad, GG; Humphrey, G; Huttenhower, C; Jain, R; Kazmierczak, BI; Knight, R; Komor, AC; Leszczynski, E; Lim, M; Lloyd-Price, J; Lumeng, JC; Mallick, H; Mazmanian, SK; Meehan, MJ; Melnik, AV; Nelson, AT; Nizet, V; Panitchpakdi, M; Patras, KA; Poulsen, O; Quinn, M; Quinn, RA; Raffatellu, M; Rhee, KE; Sandborn, WJ; Siegel, D; Thron, T; Tripathi, A; Vargas, F; Vlamakis, H; Vrbanac, A; Wang, M; Welch, RD; Weldon, KC; Xavier, RJ | 1 |
| Bucki, R; Byfield, FJ; Cruz, K; Janmey, PA; Leszczyńska, K; Mendez, G; Namiot, A; Savage, PB; Sokołowski, W; Won, E | 1 |
| Hoskins, AC; Lewindon, PJ; O'Connell, NC; Pereira, TN; Ramm, GA; Setchell, KD; Shepherd, RW; Smith, JL | 1 |
| Brega, A; Colombo, C; Fugazza, R; Giunta, A; Piceni Sereni, L; Roda, A; Roda, E | 1 |
5 other study(ies) available for cholic acid and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Elevated Levels of Toxic Bile Acids in Serum of Cystic Fibrosis Patients with
Topics: Bile Acids and Salts; Cholic Acid; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Exocrine Pancreatic Insufficiency; Glycine; Humans; Liver Diseases; Mutation; Taurine | 2022 |
Global chemical effects of the microbiome include new bile-acid conjugations.
Topics: Animals; Bile Acids and Salts; Cholic Acid; Cystic Fibrosis; Germ-Free Life; Humans; Inflammatory Bowel Diseases; Metabolomics; Mice; Microbiota; Receptors, Cytoplasmic and Nuclear | 2020 |
Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biofilms; Cholic Acid; Cystic Fibrosis; Hemolysis; Humans; Poloxamer; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Staphylococcus aureus; Steroids; Surface-Active Agents | 2011 |
Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
Topics: Adolescent; Bile Acids and Salts; Child; Child, Preschool; Cholic Acid; Cystic Fibrosis; Female; Humans; Infant; Liver Diseases; Male; Predictive Value of Tests; Prognosis; Ursodeoxycholic Acid | 2004 |
Bile acid malabsorption in cystic fibrosis with and without pancreatic insufficiency.
Topics: Adolescent; Adult; Bile Acids and Salts; Chenodeoxycholic Acid; Child; Child, Preschool; Cholic Acid; Cholic Acids; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Feces; Female; Humans; Intestinal Absorption; Male; Radioimmunoassay | 1984 |